GINKGO BIOWORKS HOLDINGS, INC. (DNA) Operating margin 2019–2025
GINKGO BIOWORKS HOLDINGS, INC. (DNA) operating margin by fiscal year — reported operating income divided by reported revenue.
-185.3%FY2025 · since FY2019: -132.1% → -185.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -185.3% | +61.3 pp |
| FY2024 | -246.5% | +97.2 pp |
| FY2023 | -343.8% | +118.6 pp |
| FY2022 | -462.4% | +120.2 pp |
| FY2021 | -582.6% | -403.9 pp |
| FY2020 | -178.8% | -46.6 pp |
| FY2019 | -132.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice